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INTRODUCTIONANDAIMS: Protein energy waste (PEW), in the context of themal-
nutrition inflammation and atherosclerosis syndrome, is a common problem in elderly
patients, even in the context of high dialysis efficiency. Increasing energy and protein
intake is usually not sufficient to reverse the syndrome, so nutritional supplements may
help to improve nutritional parameters. The best choice of nutritional supplements
and the indications for intra dialytic or extra dialysis supplements is not agreed. Aim of
this study was to analyse patients’ choices and indications for three different kinds of
supplements.
METHODS: In hospital dialysis French Centre, at time of study (December 2017), 95
chronic patients were on treatment (median comorbidity according to Charlson index
(CCI): 9; median age 73 years; medianMalnutrition inflammation Score 7 (moderate
malnutrition)). All patients with albumin level<3.5 g/dL, or with other signs of PEW
were offered 4 options: no supplements (not tasty, toomany pills etc); intradialysis sup-
plements (on the average 250 Kcal and 20 g proteins); extradialysis supplements (same
products 1-2 times per day); keto and amino acid supplements (Ketosteril 1 pill per 8-
10 Kg of body weight). Patients could choose among creams, beverages and pills, the
latter were preferred in obese patients and in patients who did not like sweet supple-
ments. The median cost for Ketosteril supplementation was 3 Euros/day, roughly
equivalent to the cost of hypercaloric and hyperprotidic beverages, creams and pills (2-
8 Euros).
RESULTS:Out of the 95 patients, 43 patients with albumin levels<3.5 g/dL accepted
nutritional supplements. 10 of them chose intradialysis supplements (mean age 67.7
years; median CCI: 9; 60% onHDF, 40% onHD); 16 were supplemented at home
(mean age 76,43 years; median CCI: 8; 62% onHD, 38% onHDF); 17 were on
Ketosteril (mean age 70,35 years; median CCI: 8; 64% onHD, 36% onHDF); 2 of them
took both Ketosteril and extradialysis supplements. Compliance was good to the three
treatments (the main reasons for discontinuation was the improvement in the nutri-
tional status). Albumin levels, taken as the main marker of malnutrition, responded to
supplementation in the absence of other events (infectious or cardiovascular). After at
least 1 month of treatment, albumin levels increased in the 90% of patients (mean
increase 0.2 g/dl; mean albumin levels pre-supplementation: 2.8 g/dl; mean albumin
levels post-supplementation: 3 g/dl), without significant differences between the three
group (p¼ 0.28). No side effect was observed.
CONCLUSIONS:An integrated, multiple-offer of intra and extradialysis supplements
may be important for allowing each patient finding the best nutritional integration.
While the frequent problems (infectious, cardiovascular, neoplasia) limit the possibility
to evaluate efficacy, the absence of side effects and the good compliance suggest extend-
ing offer of nutritional supplements to virtually all elderly and high-comorbidity dialy-
sis patients.
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INTRODUCTIONANDAIMS:Damage to the endothelial glycocalyx (eGC) is a cru-
cial step in the development of cardiovascular disease (CVD). By using a rat model, we
were able to link the protein-bound uremic toxin indoxyl sulfate (IxS) to eGC disrup-
tion as indicated by shedding of its fragments into the circulation. We therefore
hypothesize that eGC damage could be one of themechanisms by which IxS contributes
to an increased risk of CVD in chronic kidney disease (CKD) patients. To test this
hypothesis in the clinical setting, the present study investigates whether the increase in
IxS with CKD progression was accompanied by changes in markers for endothelial dys-
function and eGC disruption.
METHODS: Plasma samples were obtained frommatched healthy donors (n¼13) and
patients from CKD stage 1&2 (n¼10), CKD stage 3 (n¼7) and CKD stage 4&5 (n¼11).
Concentrations of IxS were determined by UPLC. Circulating syndecan-1 (Sdc-1; one
of the major components of the eGC), Matrix metalloproteinase 7 (MMP-7; an eGC
degrading enzyme) and different markers of endothelial dysfunction (Angiotensin 2
[Ang-2], Vascular Cell AdhesionMolecule 1 [VCAM-1], Intercellular Adhesion
Molecule 1 [ICAM-1], E-selectin, P-selectin) were simultaneously detected with a
Luminex assay (R&D systems).
RESULTS: Concentrations of IxS and Sdc-1 are both significantly higher in patients
with CKD stage 4&5 compared to the other groups. P-selectin and E-selectin were sig-
nificantly upregulated from CKD stage 3 and stage 4&5 on, respectively. Plasma levels
of MMP-7 are significantly increased at all stages of CKD compared with healthy con-
trols, andmoreover precedes the shedding of eGC degradation fragments. An incre-
ment of Ang-2 levels was observed throughout the consecutive CKD stages.
Despite the rather low predicitive power at the level of the individual patient, correla-
tions were observed between Total IxS and Sdc-1 (r¼ 0.664, p< 0.001) andMMP-7 (r
¼ 0.410, p¼ 0.01) and between Free IxS and Sdc-1 (r¼ 0.566, p< 0.001), Ang-2 (r¼
0.516, p< 0.01) andMMP-7 (r¼ 0.405, p< 0.01).
CONCLUSIONS:Notwithstanding the low number of patients, these data confirm a
possible link between IxS and eGC damage and strengthen the hypothesis that the nega-
tive impact of IxS on composite cardiovascular outcomes could be mediated by damage
to the eGC. In the near future, we will expand this cohort and link these data to cardio-
vascular events andmortality.
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INTRODUCTIONANDAIMS: Pregnancy is increasingly common in patients with
advanced or intensely proteinuric CKD, posing ethical and pragmatic problems.
Previous experiences with plant based diets showed better stabilisation of kidney func-
tion and proteinuria and equal or better foetal growth at delivery as compared with
patients on unrestricted diet. No data were so far available on fetal growth during preg-
nancy. Aim of the study was to analyse foetal growth and Doppler indexes (uterine and
umbilical arteries) in pregnant CKD patients followed-up in the same settings, who did
or did not follow the study diet in pregnancy.
METHODS: From the database of the “kidney and pregnancy” Unit, prospectively
updated since 2000, we selected all patients with at least one Doppler control in our
Center (after 24 weeks; in case of more findings we considered the last one), and with
CKD stage 3 and/or with proteinuria above 1 g at start of pregnancy or nephrotic at any
time. The patients were stratified according to the diet followed: Plant-based supple-
mentedmoderately protein-restricted diets (the cases) (protein intake 0.6-0.8 g/Kg/
day, 1-3 unrestricted meals per week, supplemented with alpha-ketoacids and aminoa-
cids 1 tablet/8 Kg of body weight); CKD unrestricted diets (due to later referral, per-
sonal choice, milder disease) (the controls). Before 2011, only patients with stage 3b-5
CKD and nephrotic proteinuria were managed with the diet; after 2011 the diet was
proposed to all patients with CKD stages 3-5 not on dialysis and with nephrotic or sub-
nephrotic proteinuria.
RESULTS:Overall, 41 patients followed the diet in pregnancy; 34 were selected for the
study (3 twin pregnancies, 2 patients without ecographic data, 1 miscarriage and 1 vol-
untary termination were excluded); the control group consisted of 20 patients (5 mis-
carriages were excluded). The 2 groups were similar for age and BMI; proteinuria was
non-significantly higher in on-diet patients, CKD stage and creatinine were non-signif-
icantly higher in the control group. No difference was found as for neonatal weight, ges-
tational age at referral, caesarean section, birth weight centile. Prevalence of uterine
Doppler flow impairment was non-significantly higher in control patients, while the
difference in umbilical Doppler flow, better preserved in on-diet patients, was highly
significant (p¼0.009). The incidence of foetal growth restriction (FGR) was lower in
on-diet patients (5.9%) than in control group (25%), but statistical significance was
not reached (p¼0.057) (Table).
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